Speciality Medicines Limited (BOM:544738)
India · Delayed Price · Currency is INR 178.10
-8.90 (-4.76%)
At close: Jul 31, 2026
Speciality Medicines Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 130.33 | 71.96 | 40.51 | 22.01 | 14.79 |
Depreciation & Amortization | 1.72 | 1.89 | 2.32 | 2.95 | 1.12 |
Other Amortization | - | 0.09 | - | - | - |
Other Operating Activities | 13.36 | 5.39 | 6.14 | 3.66 | 6.98 |
Change in Accounts Receivable | -168.96 | 11.09 | -52.07 | -29.15 | -25.91 |
Change in Inventory | -109.41 | -93.45 | -34.36 | -41.13 | -4.83 |
Change in Accounts Payable | 109.45 | -14.44 | 6.13 | 6.2 | 11.83 |
Change in Other Net Operating Assets | 10.7 | -46.84 | -16.67 | -1.43 | 4.08 |
Operating Cash Flow | -12.81 | -64.32 | -48 | -36.89 | 8.06 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0.08 | -6.07 | -0.25 | -0.8 | -20.93 |
Investment in Securities | -2.02 | -0.02 | - | 1.11 | -2.11 |
Other Investing Activities | -26.24 | -8.22 | - | - | - |
Investing Cash Flow | -28.34 | -14.31 | -0.25 | 0.32 | -23.34 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 4.25 | 0.87 | - | 11.78 |
Long-Term Debt Issued | 24.1 | 17.63 | - | 19.49 | - |
Total Debt Issued | 24.1 | 21.89 | 0.87 | 19.49 | 11.78 |
Short-Term Debt Repaid | -8.15 | - | - | - | - |
Long-Term Debt Repaid | - | - | -8.68 | - | - |
Total Debt Repaid | -8.15 | - | -8.68 | - | - |
Net Debt Issued (Repaid) | 15.96 | 21.89 | -7.82 | 19.49 | 11.78 |
Issuance of Common Stock | 291.4 | 67.44 | 66.5 | 51.88 | 4.53 |
Other Financing Activities | -29.21 | -4.73 | -10.55 | -32.94 | -0.27 |
Financing Cash Flow | 278.15 | 84.6 | 48.13 | 38.42 | 16.04 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | 0 |
Net Cash Flow | 237 | 5.97 | -0.13 | 1.85 | 0.77 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -12.89 | -70.39 | -48.25 | -37.69 | -12.87 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -1.71% | -12.08% | -17.53% | -16.22% | -3.18% |
Free Cash Flow Per Share | -1.99 | -10.94 | -9.43 | -10.53 | -4.23 |
Levered Free Cash Flow | -80.42 | -94.6 | -60.54 | -50.54 | - |
Unlevered Free Cash Flow | -72.17 | -92.36 | -56.76 | -48.4 | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 13.19 | 3.58 | 6.05 | 3.42 | 0.27 |
Cash Income Tax Paid | - | 14.94 | - | 7.47 | - |
Change in Working Capital | -158.22 | -143.64 | -96.98 | -65.51 | -14.83 |